ArticleVascular medicine (London, England)2021
North American lower-extremity revascularization and amputation during COVID-19: Observations from the Vascular Quality Initiative.
Article in Vascular medicine (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Influence of the COVID-19 pandemic on the amputation rate in Germany in patients with critical limb-threatening ischaemia.Innovative surgical sciences · 2025Article
- The Sustained Impact of the COVID-19 Pandemic on Vascular Surgical Care Delivery.Annals of vascular surgery · 2024Article
- Impact of the COVID-19 pandemic on patients with peripheral arterial disease in China: a multicenter cross-sectional study.Scientific reports · 2024Article
- Sex and Racial Disparities in Peripheral Artery Disease.Arteriosclerosis, thrombosis, and vascular biology · 2023Review
- The indirect impact of COVID-19 pandemic on limb preservation care- a retrospective analysis of trends in lower limb revascularisation.Journal of foot and ankle research · 2023Article
- Editor's Choice - Outcomes of Surgery for Patients with Peripheral Arterial Disease During the COVID-19 Pandemic in the United Kingdom: A Population Based Study.European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2023Article
- A review of disparities in peripheral artery disease and diabetes-related amputations during the COVID-19 pandemic.Seminars in vascular surgery · 2023Review
- Impact of COVID-19 Pandemic on Clinical Care of Peripheral Arterial Disease Patients: A Single-Center Experience.Journal of clinical medicine · 2023Article
- Peripheral Artery Disease Causes More Harm to Patients than COVID-19.Healthcare (Basel, Switzerland) · 2022Article
- Impact of the COVID-19 Pandemic on In-Patient Treatment of Peripheral Artery Disease in Germany during the First Pandemic Wave.Journal of clinical medicine · 2022Article
Corrections and comments
- Commented on by
Authors and funding
10 authors.
Funding
Abstract
introductionThe coronavirus disease 2019 (COVID-19) pandemic's impact on vascular procedural volumes and outcomes has not been fully characterized.
methodsVolume and outcome data before (1/2019 - 2/2020), during (3/2020 - 4/2020), and following (5/2020 - 6/2020) the initial pandemic surge were obtained from the Vascular Quality Initiative (VQI). Volume changes were determined using interrupted Poisson time series regression. Adjusted mortality was estimated using multivariable logistic regression.
resultsThe final cohort comprised 57,181 patients from 147 US and Canadian sites. Overall procedure volumes fell 35.2% (95% CI 31.9%, 38.4%,
conclusionThe first North American COVID-19 pandemic surge was associated with a significant and sustained decline in both elective and nonelective lower-extremity vascular procedural volumes. When compared with presurge patients, in-hospital mortality increased for those with claudication and ALI following the surge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.